Introduction
Although intracranial complications of sinus disease are uncommon since the advent of antibiotics, 1 the consequences of intracranial spread can be dismal if not recognized early. The subtle presentation of sphenoid sinusitis often leads to a delay in diagnosis. The disease may go unrecognized until complications are severe enough to cause more localizing symptoms. The incidence of cerebral sinovenous thrombosis (CSVT) arising from sphenoid sinusitis is rare; when it occurs, it typically affects the cavernous sinus. 1 Thrombosis of the sigmoid sinus is classically associated with acute or chronic otitis media. 2 We report a case of sphenoid sinusitis complicated by meningitis as well as lateral and sigmoid venous sinus thrombosis.
Case report
A 14-year-old boy presented to the emergency room and to his primary care physician multiple times complaining of frontal headache radiating to the right parietal region and fever up to 38.8°C. At his initial ER visit, he had no complaints of malaise, nasal congestion, rhinorrhea, vomiting, or anorexia. He had undergone tonsillectomy and adenoidectomy, but no other significant illnesses were identified in his history.
The patient was initially given amantidine and ibuprofen for the diagnosis of flu. Two weeks after symptom onset, he developed agitation and confusion and returned to the ER. He was noted on examination to have nuchal rigidity, and he also complained of decreased appetite. A lumbar puncture was performed, revealing increased white blood cells (8,237/µl), increased protein (>500 mg/dl), and decreased glucose (<25 mg/dl), yet a Gram stain and culture were negative. He was then intubated and transferred to Le Bonheur Children's Hospital.
Computed tomography (CT) of the head without contrast revealed sphenoid sinusitis without other abnormalities. The patient was started on what was intended to be a 6-week course of IV vancomycin 1 g every 8 hours and meropenem 2 g every 8 hours. Cerebrospinal fluid was obtained for polymerase chain reaction testing for Streptococcus pneumoniae, which was subsequently found to be positive.
Repeat CT scans with contrast (figure 1) and without contrast performed the next day revealed left transverse and sigmoid sinus thrombosis. Magnetic resonance imaging (MRI) with a magnetic resonance venogram (MRV) was performed for further evaluation (figure 2, A). MRI confirmed thrombosis of the left transverse sinus from its origin of the sinus confluence to the sigmoid sinus, as well as a filling defect on MRV. The patient was taken to the operating room for endoscopic sphenoidotomy, and pus was sent for culture. The patient was started on heparin for 3 days, and then enoxaparin was begun and maintained at therapeutic levels. The patient developed epistaxis within 48 hours of starting the enoxaparin, and he required nasal mucosal cautery. Another episode of epistaxis occurred that was treated with nasal packing and oxymetazoline nasal spray.
Enoxaparin was continued because of the patient's risk of clot progression, but the dose was lowered from 60 mg to 40 mg after the patient developed hematuria secondary to nephrolithiasis. The patient's epistaxis was controlled without causing symptomatic anemia. Although he did have a drop in hemoglobin, white blood cells, and platelets about 4 days after enoxaparin was started, the drop was suspected to be from bone marrow suppression secondary to the meropenem, which was changed to metronidazole.
The patient showed continued improvement and was discharged home on IV vancomycin and metronidazole. A follow-up MRI with MRV 1 month later showed no filling defects within the intracranial sinuses to suggest venous thrombosis ( figure 2, B ).
Discussion
Inflammatory sinusitis usually involves multiple paranasal sinuses and is diagnosed based on symptoms of purulent nasal discharge, maxillary or frontal facial tenderness, or nasal obstruction. 3 Isolated sphenoid sinusitis (ISS) presents as headache in 69 to 98% of patients; 1 the vague symptoms are likely because of the location of the sinus deep within the cranial cavity. The deep position of this sinus facilitates spread of infection into intracranial structures.
Anatomy accounts for the mechanisms of infection spread in septic cavernous sinus thrombosis from ISS, and in lateral sinus thrombosis from otitis media. Blood from the sphenoid sinus drains into the cavernous sinus through communicating veins in the intervening bone. The cavernous sinuses and their connections lack valves, thus allowing bidirectional spread of infection and thrombi. 4 Lateral sinus thrombosis secondary to otitis media occurs from the venous spread of infection from the mastoid emissary vein into the sigmoid sinus. 5 Neither of these mechanisms can explain the presence of lateral sinus thrombosis from the sphenoid sinus. To our knowledge, we report the first case of sphenoid sinusitis leading to lateral and sigmoid sinus thrombosis.
Diagnosis of sinus thrombosis requires a high index of suspicion, and the clinician must be aware of the range of possible symptoms. Age can assist in this diagnosis. For example, presentation of sinovenous thrombosis differs between neonates (less than 1 month old) and non-neonates (1 month to 18 years old). Head and neck disorders, including infection, are common to both neonates and non-neonates. However, neonates more often present with seizures, and non-neonates have focal neurologic signs and headache. 6 For nonneonates to present with seizures has been found to be a predictor of an adverse neurologic outcome. 6 Pediatric sinovenous thrombosis has important clinical implications; some reports indicate a mortality rate of 16% and a morbidity rate of 22%. 7 A multicenter cohort study predicted the overall yearly rate of a second venous thrombosis event was 22.2 per 1,000 person-years within a median period of 6 months after a first venous thrombosis. 6 These patients were not on anticoagulant treatment at the time of recurrence but had completed the standard 3 to 6 months of therapy. Risk factors for recurrent venous thrombosis in children >2 years of age have been found to include failure to recanalize and the presence of a prothrombin G20210A mutation. 8 Sinovenous thrombosis can lead to death or longterm neurologic sequelae; therefore, appropriate treatment is essential. Parenteral antibiotics are the cornerstone of therapy. Opinions differ regarding the use of anticoagulation and surgical management of CSVT. Much of the evidence regarding anticoagulation for pediatric patients has been extrapolated from studies in adults. However, children have maturational differences in coagulation and in cerebrovascular and neurologic systems, so treating them according to adult protocols may not confer the same results. 6 Although it has been suggested that a thrombus may play a protective role by confining the infection and thus preventing septic emboli, a thrombus can harbor bacteria, making antibiotic penetration difficult unless the thrombus recanalizes. 5 The risk of systemic and intracranial bleeding must be weighed against the benefit of limiting clot progression. Anticoagulation promotes intracranial venous drainage that restricts the effects of increased intracranial pressure. 7 Unfractionated heparin has been used as the drug of choice perioperatively because of its rapid onset of action, short half-life, and easy reversibility. Low-molecular-weight heparin, despite its difficulty with rapid reversal, offers the advantage of twice-daily subcutaneous dosing and less risk of heparin-induced thrombocytopenia. Use of heparin in the initial stages of septic CSVT can be converted to longer-acting agents once a patient has been stabilized, 5 as seen in the management of our patient.
Surgery typically involves drainage of the primary infection source or other concurrent closed-space infections. Sinogenic cavernous sinus thrombosis operations, such as transseptal sphenoidotomy and endoscopic sphenoidectomy, are performed to decom-press the sinuses. 5 Our patient also underwent sinus surgery to address what we believed to be his primary infection source.
Although our case resulted in a good outcome despite the delayed diagnosis, awareness of this disease is essential so that appropriate treatment may be started early to prevent complications or to prevent the morbidity and mortality associated with the complications of sinus disease. 
